tafluprost

Generic: tafluprost

Labeler: ingenus pharmaceuticals, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name tafluprost
Generic Name tafluprost
Labeler ingenus pharmaceuticals, llc
Dosage Form SOLUTION/ DROPS
Routes
OPHTHALMIC
Active Ingredients

tafluprost .015 mg/mL

Manufacturer
Ingenus Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 50742-339
Product ID 50742-339_9ebbfaa4-b3c0-46d2-bc83-9817b2d238df
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA218002
Listing Expiration 2026-12-31
Marketing Start 2024-12-18

Pharmacologic Class

Established (EPC)
prostaglandin analog [epc]
Mechanism of Action
prostaglandin receptor agonists [moa]
Chemical Structure
prostaglandins [cs]
Physiologic Effect
increased prostaglandin activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50742339
Hyphenated Format 50742-339

Supplemental Identifiers

RxCUI
1244611
UNII
1O6WQ6T7G3
NUI
N0000175454 N0000000106 N0000009526 M0017805

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tafluprost (source: ndc)
Generic Name tafluprost (source: ndc)
Application Number ANDA218002 (source: ndc)
Routes
OPHTHALMIC
source: ndc

Resolved Composition

Strengths
  • .015 mg/mL
source: ndc
Packaging
  • 6 POUCH in 1 CARTON (50742-339-30) / 5 VIAL, SINGLE-DOSE in 1 POUCH (50742-339-05) / .3 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

Ingredients (1)

tafluprost (.015 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["OPHTHALMIC"], "spl_id": "9ebbfaa4-b3c0-46d2-bc83-9817b2d238df", "openfda": {"nui": ["N0000175454", "N0000000106", "N0000009526", "M0017805"], "unii": ["1O6WQ6T7G3"], "rxcui": ["1244611"], "spl_set_id": ["5d766054-d13f-462c-bf8a-6462e56ca097"], "pharm_class_cs": ["Prostaglandins [CS]"], "pharm_class_pe": ["Increased Prostaglandin Activity [PE]"], "pharm_class_epc": ["Prostaglandin Analog [EPC]"], "pharm_class_moa": ["Prostaglandin Receptor Agonists [MoA]"], "manufacturer_name": ["Ingenus Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "6 POUCH in 1 CARTON (50742-339-30)  / 5 VIAL, SINGLE-DOSE in 1 POUCH (50742-339-05)  / .3 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "50742-339-30", "marketing_start_date": "20241218"}], "brand_name": "Tafluprost", "product_id": "50742-339_9ebbfaa4-b3c0-46d2-bc83-9817b2d238df", "dosage_form": "SOLUTION/ DROPS", "pharm_class": ["Increased Prostaglandin Activity [PE]", "Prostaglandin Analog [EPC]", "Prostaglandin Receptor Agonists [MoA]", "Prostaglandins [CS]"], "product_ndc": "50742-339", "generic_name": "Tafluprost", "labeler_name": "Ingenus Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tafluprost", "active_ingredients": [{"name": "TAFLUPROST", "strength": ".015 mg/mL"}], "application_number": "ANDA218002", "marketing_category": "ANDA", "marketing_start_date": "20241218", "listing_expiration_date": "20261231"}